AUC	area under the curve
BEV	bacterial extracellular vesicle
BFT	bacteroides fragilis toxin
CRC	colorectal cancer
CAR	chimeric antigen receptor
DC	dendritic cell
DCA	deoxycholic acid
DCR	disease control rate
dMMMR	mismatch repair-deficient
ETBF	enterotoxigenic Bacteroides fragilis
FMT	fecal microbiota transplantation
ICI	immune checkpoint inhibitor
mCRC	metastatic colorectal cancer
MSI-H	high microsatellite instability
MSS	microsatellite-stable
MDSC	myeloid-derived suppressor cell
NET	neutrophil extracellular trap
NGP	next-generation probiotic
NK	natural killer
NLR	neutrophil-to-lymphocyte ratio
NSCLC	non-small-cell lung cancer
ORR	objective response rate
OS	overall survival
OTC	over-the-counter
PD-1	programmed cell death protein 1
PD-L1	programmed death-ligand 1
pMMR	proficient mismatch repair
PFS	progression-free survival
RCT	randomized controlled trial
SCFA	short-chain fatty acid
TIGIT	T-cell immunoreceptor with immunoglobulin and ITIM domains
TIME	tumor immune microenvironment